Paulson & Co’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Paulson & Co’s Portfolio ISEE Stock Details ISEE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-25,000	Closed	-$984K	–	20
2023 Q2	$984K	Buy	+25,000	New	+$882K	0.1%	20

Paulson & Co's ISEE Position: Q3 2023 in Review

Paulson & Co sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 25,000 shares — an estimated $984K sold.

Paulson & Co first reported a position in ISEE in Q2 2023 and held it in 1 quarter. The position peaked at $984K in Q2 2023. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.

Paulson & Co reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Paulson & Co sold 25,000 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $984K.
Paulson & Co first reported a position in IVERIC bio, Inc. Common Stock in Q2 2023 and held it in 1 quarter.
Paulson & Co's IVERIC bio, Inc. Common Stock position peaked at $984K in Q2 2023.
0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.

Based on Paulson & Co's 13F filing for Q3 2023, filed 14 Nov 2023.